Gastroparesis Market Expected To Grow At 5.5% CAGR Through 2030: What Businesses Need To Know

Gastroparesis Market Report

Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.

Gastroparesis Market Revenue Growth On Track For A 5.5% CAGR Through 2030

The gastroparesis market has experienced robust growth in recent years. It is projected to expand from $7.15 billion in 2025 to $7.52 billion in 2026, achieving a compound annual growth rate (CAGR) of 5.1%. The historical increase in this market can be attributed to elements like diabetes-related gastric disorders, the application of antiemetic medications, hospital-based GI care, various dietary management approaches, and the accessibility of diagnostic imaging.

The gastroparesis market is projected to experience substantial expansion in the coming years, set to reach a valuation of $9.29 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 5.5%. Factors contributing to this anticipated growth include advancements in implantable stimulation devices, the rise of outpatient treatment approaches, an increasing diabetic population, the need for therapies targeting specific symptoms, and enhanced clinical understanding. Key trends anticipated during this period encompass a greater reliance on prokinetic medications, wider acceptance of gastric electrical stimulation devices, an elevated emphasis on managing diet and lifestyle, the availability of more minimally invasive surgical choices, and more accurate diagnosis of diabetic gastroparesis.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=38569581&type=smp&name=Gastroparesis%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Nov_PR

Gastroparesis Market Industry Drivers: What’s Behind The Revenue Growth?

The escalating incidence of diabetes is projected to fuel the expansion of the gastroparesis market in the future. Diabetes is a long-term health issue marked by high blood sugar, occurring when the body fails to produce sufficient insulin or utilize it efficiently. The widespread occurrence of diabetes substantially raises the probability of developing gastroparesis, given its critical role in enlarging the demographic susceptible to this ailment. For example, the International Diabetes Federation, an advocacy body based in Belgium, reported in April 2025 that approximately one in nine adults worldwide (589 million) currently live with diabetes. Out of this total, an estimated 252 million individuals remain undiagnosed, putting them at an elevated risk of severe complications and premature mortality. Consequently, the swift increase in diabetes prevalence is propelling the gastroparesis market.

Gastroparesis Market Segment Landscape: Which Areas Lead Development?

The gastroparesis market covered in this report is segmented –

1) By Treatment Modality: Medications, Dietary Modifications, Medical Devices, Other Therapies

2) By Gastroparesis Type: Idiopathic, Diabetic, Post- Surgical, Other Types

3) By Patient Demographics: Pediatric Gastroparesis, Adult Gastroparesis

4) By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, Other Distribution Channels

5) By End User: Hospitals And Clinics, Ambulatory Surgical Centers, Home Care Settings

Subsegments:

1) By Medications: Prokinetic Agents, Antiemetic Medications, Pain Management Medications

2) By Dietary Modifications: Low-Fiber Diets, Small, Frequent Meals, Pureed Or Liquid Diets

3) By Medical Devices: Gastric Electrical Stimulation Devices, Enteral Feeding Tubes

4) By Other Therapies: Acupuncture, Behavioral Therapies, Nutritional Supplements

Gastroparesis Market Growth Trends Reshaping The Competitive Landscape

Major companies within the gastroparesis market are actively developing pharmaceuticals to enhance their profitability in the sector. Medications utilized in managing gastroparesis aim to alleviate various symptoms associated with delayed gastric emptying. For instance, in December 2023, Vanda Pharmaceuticals Inc., a US-based biopharmaceutical entity, reported that the U.S. FDA accepted the New Drug Application for Tradipitant, a significant step towards its potential endorsement for gastroparesis therapy. The FDA has scheduled September 18, 2024, as the decision date for Tradipitant, as per the Prescription Drug User Fee Act (PDUFA). If successful, Tradipitant would represent the first novel FDA-approved drug for gastroparesis in over 40 years, signifying a crucial achievement as the first drug in more than three decades to undergo FDA review specifically for this condition.

Gastroparesis Market Industry Leaders And Competitive Landscape

Major companies operating in the gastroparesis market are Pfizer Inc., GlaxoSmithKline plc., Abbott Laboratories Inc., AstraZeneca Plc., Medtronic Plc., Takeda Pharmaceutical Company Limited, Johnson And Johnson Services Inc., Teva Pharmaceutical Industries Ltd, AbbVie Inc., Boston Scientific Corporation, Cadila Pharmaceuticals Ltd., Daewoong Pharmaceutical Co. ltd, ANI Pharmaceuticals Inc., Dompe Farmaceutici S.p.A, Sucampo Pharmaceuticals Inc., Ironwood Pharmaceuticals Inc., RedHill Biopharma Ltd., CinRx Pharma LLC, Ritter Pharmaceuticals Inc., Evoke Pharma Inc., Metacrine Inc., Neurogastrx Inc.

View The Full Gastroparesis Market Report:

https://thebusinessresearchcompany.com/report/gastroparesis-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Nov_PR

Gastroparesis Market Regional Split: Which Areas Are Fueling Growth?

North America was the largest region in the gastroparesis market in 2025. The regions covered in the gastroparesis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model